• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    The Honest Company Announces Appointment of Michael Barkley, Alissa Hsu Lynch, and Andrea Turner to the Board of Directors

    12/11/23 9:00:00 AM ET
    $HNST
    $LUNG
    Catalog/Specialty Distribution
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $HNST alert in real time by email

    LOS ANGELES, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced that Michael Barkley, Former Chief Executive Officer of Kind LLC, Alissa Hsu Lynch, Former Global Head of MedTech Strategy and Solutions for Google Cloud, and Andrea Turner, Former Senior Vice President, Global Customer Service & Logistics at Mondelēz International, Inc., have been appointed to its Board of Directors effective December 8, 2023.

    "We are pleased to welcome Michael, Alissa and Andrea to our board of directors. All three leaders are proven experts in the consumer goods space. Their retail and digital expertise will strengthen our board by adding significant capabilities that support the company's growth plans." said Carla Vernón, CEO of The Honest Company. "I look forward to partnering with our entire board as we continue to advance our Transformation Initiative and long-term strategy in 2024."

    Barkley, a seasoned consumer products executive, most recently served as the CEO of KIND LLC. At KIND, Barkley led the business through a new era of growth and expansion. He also spearheaded transformational change and performance acceleration at Pinnacle Foods and Johnson & Johnson. Barkley is a visionary leader who builds organizational capabilities to enable high-performing teams and deliver enduring value creation.

    Lynch is an experienced industry leader across consumer products, healthcare, and technology. At Google, she worked with Fortune 500 companies to drive digital transformation in healthcare using data, analytics, and AI. Previously, she was Vice President at Johnson & Johnson, where she held P&L and strategy roles leading billion-dollar global businesses in the MedTech and Consumer Health sectors, including Baby and Skin Care. She currently serves on the Board of Directors of Pulmonx (NASDAQ:LUNG).

    Turner, a global leader in supply chain and logistics management has a successful background which includes transformational impact at Fortune 500 companies across consumer goods, biotech and pharmaceuticals. As Senior Vice President, Global Customer Service and Logistics at Mondelēz, she strategized and led logistics during the COVID-19 pandemic for the $25 billion supply chain across 80 countries. Turner was also responsible for driving teams to solve complex supply chain problems at General Mills and Merck, delivering improved productivity and accelerating growth.

    "Honest continues to drive strong performance and demonstrate the power of our brand. As we continue on this journey to drive stakeholder value, we welcome Michael, Alissa and Andrea's expertise. They join Honest during an exciting and pivotal time for the brand and I am confident these additions further transform the board as the company evolves our growth strategy," said James D. White, Chair of the Board of The Honest Company. "Their diverse backgrounds and areas of expertise will help elevate us to new heights for consumers and push our thinking even further."

    Forward-Looking Statements

    All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will" or "would" or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements concerning the Company's performance and brand and the Company's ability to deliver on its Transformation Initiative and drive stakeholder value. You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this press release primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled "Risk Factors" in the Annual Report, on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 16, 2023, and Quarterly Report on Form 10-Q for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023, respectively, filed with the Securities and Exchange Commission on May 9, 2023, August 8, 2023 and November 8, 2023, respectively, and subsequent filings with the Securities and Exchange Commission. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this press release or the earnings call referencing this press release. The results, events and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements.

    About The Honest Company

    The Honest Company (NASDAQ:HNST) is a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care. Honest products are available via Honest.com, third-party ecommerce customers and approximately 51,000 retail locations across the United States, Canada and Europe. Based in Los Angeles, CA, the Company's mission, to inspire everyone to love living consciously, is driven by its values of transparency, trust, sustainability and a deep sense of purpose around what matters most to its consumers: their health, their families and their homes. For more information about the Honest Standard and the Company, please visit www.honest.com.

    Investor Contact:

    Elizabeth Bouquard

    [email protected] 

    Media Contact:

    Jennifer Kroog Rosenberg

    [email protected] 



    Primary Logo

    Get the next $HNST alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HNST
    $LUNG

    CompanyDatePrice TargetRatingAnalyst
    Pulmonx Corporation
    $LUNG
    3/10/2025$17.00Buy
    D. Boral Capital
    The Honest Company Inc.
    $HNST
    1/10/2025$6.00 → $7.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    12/17/2024$7.00Buy → Hold
    Loop Capital
    Pulmonx Corporation
    $LUNG
    12/11/2024$17.00 → $7.50Buy → Neutral
    Citigroup
    The Honest Company Inc.
    $HNST
    11/13/2024$4.00 → $6.00Market Perform
    Telsey Advisory Group
    The Honest Company Inc.
    $HNST
    11/13/2024$5.75 → $8.00Buy
    Alliance Global Partners
    The Honest Company Inc.
    $HNST
    9/10/2024$6.50Buy
    B. Riley Securities
    The Honest Company Inc.
    $HNST
    8/6/2024$6.00Outperform
    Northland Capital
    More analyst ratings

    $HNST
    $LUNG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director French Glendon E. Iii sold $157,000 worth of shares (20,000 units at $7.85), decreasing direct ownership by 2% to 991,974 units (SEC Form 4)

      4 - Pulmonx Corp (0001127537) (Issuer)

      3/21/25 6:14:28 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • SVP, Supply Chain Von Kunssberg Etienne was granted 115,122 shares (SEC Form 4)

      4 - Honest Company, Inc. (0001530979) (Issuer)

      3/18/25 6:24:40 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chief Innovation Officer Winchell Stephen sold $99,600 worth of shares (20,000 units at $4.98), decreasing direct ownership by 4% to 431,844 units (SEC Form 4)

      4 - Honest Company, Inc. (0001530979) (Issuer)

      3/14/25 4:45:12 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary

    $HNST
    $LUNG
    SEC Filings

    See more
    • SEC Form 10-Q filed by The Honest Company Inc.

      10-Q - Honest Company, Inc. (0001530979) (Filer)

      5/7/25 4:16:49 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • The Honest Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Honest Company, Inc. (0001530979) (Filer)

      5/7/25 4:15:57 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SCHEDULE 13G/A filed by Pulmonx Corporation

      SCHEDULE 13G/A - Pulmonx Corp (0001127537) (Subject)

      5/7/25 11:47:10 AM ET
      $LUNG
      Medical/Dental Instruments
      Health Care

    $HNST
    $LUNG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • The Honest Company Reports First Quarter 2025 Results

      Achieves Quarterly Revenue of $97 Million, an Increase of 13% from Prior Year QuarterDelivers Net Income of $3 Million and Expands Gross Margin 170 Basis Points to 39% from Prior Year QuarterReaffirms Full Year 2025 Financial Outlook LOS ANGELES, May 07, 2025 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today reported financial results for the three months ended March 31, 2025. First Quarter 2025 Financial Highlights Compared to Prior Year Period: Revenue of $97 million increased 13%Gross margin of 39% expanded 170 basis pointsNet income of $3 million, compared to net loss of $1

      5/7/25 4:07:00 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • The Honest Company Announces Appointment of Curtiss Bruce as Chief Financial Officer

      LOS ANGELES, May 07, 2025 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today announced the appointment of Curtiss Bruce, seasoned finance executive, as the Company's new Chief Financial Officer, effective June 2, 2025. Curtiss brings over 30 years of experience, including 10 years in executive-level finance roles, in the consumer products sector. He currently serves as Senior Vice President, Corporate Financial Planning and Analysis and Investor Relations at Hain Celestial Group. In this role, he has been instrumental in building and strengthening the Company's global financial c

      5/7/25 4:02:00 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference

      REDWOOD CITY, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx") a global leader in minimally invasive treatments for severe lung disease, today announced the company will be presenting at the Bank of America Securities 2025 Health Care Conference in Las Vegas on Wednesday, May 14, 2025, at 9:35 AM PT / 12:35 PM ET. A live and archived webcast of the presentation will be available on "Investors" section of the Pulmonx website at https://investors.pulmonx.com/. About Pulmonx CorporationPulmonx Corporation (NASDAQ:LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx's Zephyr® Endobronchial Va

      5/1/25 4:05:00 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care

    $HNST
    $LUNG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $HNST
    $LUNG
    Financials

    Live finance-specific insights

    See more
    • Amendment: SEC Form SC 13G/A filed by Pulmonx Corporation

      SC 13G/A - Pulmonx Corp (0001127537) (Subject)

      11/14/24 7:47:49 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

      SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

      11/14/24 6:19:57 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by The Honest Company Inc.

      SC 13G/A - Honest Company, Inc. (0001530979) (Subject)

      11/14/24 5:53:21 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • The Honest Company Announces Appointment of Curtiss Bruce as Chief Financial Officer

      LOS ANGELES, May 07, 2025 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today announced the appointment of Curtiss Bruce, seasoned finance executive, as the Company's new Chief Financial Officer, effective June 2, 2025. Curtiss brings over 30 years of experience, including 10 years in executive-level finance roles, in the consumer products sector. He currently serves as Senior Vice President, Corporate Financial Planning and Analysis and Investor Relations at Hain Celestial Group. In this role, he has been instrumental in building and strengthening the Company's global financial c

      5/7/25 4:02:00 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Pulmonx Reports First Quarter 2025 Financial Results

      REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of 2025 ended March 31, 2025. Recent Highlights Achieved worldwide revenue of $22.5 million in the first quarter of 2025, a 20% increase over the same period last year and an increase of 21% on a constant currency basisDelivered $8.3 million in international revenue in the first quarter of 2025, representing 39% year-over-year growth and an increase of 43% on a constant currency basisDelivered $14.2 million in U.S. revenue in the first quarter of 20

      4/30/25 4:05:00 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • The Honest Company to Report First Quarter Financial Results on May 7, 2025

      LOS ANGELES, April 23, 2025 (GLOBE NEWSWIRE) -- The Honest Company (NASDAQ:HNST), a personal care company dedicated to creating cleanly-formulated and sustainably-designed products, today announced that it will report first quarter 2025 financial results after the market closes on Wednesday, May 7, 2025. The Company will host an investor conference call and webcast to review first quarter 2025 financial results at 1:45pm PT/4:45pm ET on the same day. The live webcast can be accessed at https://investors.honest.com. For those interested in participating in the conference call by phone, please go to this link: https://register-conf.media-server.com/register/BI2f586548a5c5439f921a67b858396a1

      4/23/25 5:15:00 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary

    $HNST
    $LUNG
    Leadership Updates

    Live Leadership Updates

    See more
    • Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

      REDWOOD CITY, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the appointment of Mehul Joshi as Chief Financial Officer, effective April 3, 2024. He succeeds John McKune, who has served as the Company's Interim Chief Financial Officer since October 10, 2023, and will transition to his prior role as Vice President, Corporate Controller. "Mehul is an exceptionally accomplished financial executive and I am excited to welcome him to our leadership team. His proven track record of leading global finance teams within large, diversified companies makes him

      4/2/24 4:05:00 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

      REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (NASDAQ:LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that Glen French will retire as the Company's President and Chief Executive Officer, effective March 15, 2024, following over nine years of service to Pulmonx. Concurrently, the Company announced the appointment of Steve Williamson as President and Chief Executive Officer, and as a member of the Company's Board of Directors, also effective March 15, 2024. Mr. French will serve as a Senior Advisor to Mr. Williamson until May 1, 2024 to ensure a seamless transition and then remain a member of

      2/21/24 4:05:00 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • The Honest Company Announces Appointment of Dorria L. Ball as Chief People Officer

      LOS ANGELES, Jan. 05, 2024 (GLOBE NEWSWIRE) -- The Honest Company, a digitally-native consumer products company dedicated to creating clean- and sustainably-designed products spanning baby care, beauty, personal care, wellness and household care, today announced Dorria L. Ball as the Company's new Chief People Officer (CPO), effective immediately. Ball has served in this role on an interim basis since August of 2023. Reporting directly to Carla Vernón, CEO of The Honest Company, Ball will continue working alongside Honest's executive leadership team and Board of Directors as the leader of the People & Workplace function. "At Honest, we believe that values, business performance, DEI, and

      1/5/24 4:00:00 PM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary

    $HNST
    $LUNG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • PRESIDENT AND CEO Williamson Steven S. bought $97,436 worth of shares (14,245 units at $6.84), increasing direct ownership by 7% to 219,531 units (SEC Form 4)

      4 - Pulmonx Corp (0001127537) (Issuer)

      8/22/24 6:41:17 PM ET
      $LUNG
      Medical/Dental Instruments
      Health Care

    $HNST
    $LUNG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • D. Boral Capital initiated coverage on Pulmonx with a new price target

      D. Boral Capital initiated coverage of Pulmonx with a rating of Buy and set a new price target of $17.00

      3/10/25 8:07:21 AM ET
      $LUNG
      Medical/Dental Instruments
      Health Care
    • Telsey Advisory Group reiterated coverage on Honest Company with a new price target

      Telsey Advisory Group reiterated coverage of Honest Company with a rating of Market Perform and set a new price target of $7.00 from $6.00 previously

      1/10/25 8:04:33 AM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Honest Company downgraded by Loop Capital with a new price target

      Loop Capital downgraded Honest Company from Buy to Hold and set a new price target of $7.00

      12/17/24 8:04:54 AM ET
      $HNST
      Catalog/Specialty Distribution
      Consumer Discretionary